Market Tracker

09/23 2:22pm ET
10.44
Real-Time Quote
 -0.01 / -0.10%
Today’s Change
5.62
Today|||52-Week Range
11.01
+38.55%
Year-to-Date

Today’s Trading

Previous close10.45
Today’s open10.17
Day’s range10.14 - 10.63
Volume302,144
Average volume (3 months)1,085,994
Market cap$1.4B
Dividend yield--
Data as of 2:06pm ET, 09/23/2014

Growth & Valuation

Earnings growth (last year)+13.33%
Earnings growth (this year)+28.02%
Earnings growth (next 5 years)+18.64%
Revenue growth (last year)-1.32%
P/E ratioNM
Price/Sales15.17
Price/Book48.32

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics+0.10+0.80%
KERXKeryx Biopharmaceuti...-0.18-1.39%
ABCOAdvisory Board Co-1.16-2.53%
ARIAARIAD Pharmaceutical...-0.01-0.18%
Data as of 2:21pm ET, 09/23/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$53.9M
Annual profit (last year)-$27.8M
Net profit margin-51.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gustav A. Christensen
Chief Financial Officer &
Executive Vice President
George V. Migausky
Corporate headquarters
Burlington, Massachusetts

Forecasts